SE9803773D0 - Compounds - Google Patents

Compounds

Info

Publication number
SE9803773D0
SE9803773D0 SE9803773A SE9803773A SE9803773D0 SE 9803773 D0 SE9803773 D0 SE 9803773D0 SE 9803773 A SE9803773 A SE 9803773A SE 9803773 A SE9803773 A SE 9803773A SE 9803773 D0 SE9803773 D0 SE 9803773D0
Authority
SE
Sweden
Prior art keywords
compounds
tautomers
prophylaxis
enantiomers
pain
Prior art date
Application number
SE9803773A
Other languages
Swedish (sv)
Inventor
Anthony Cook
Peter Hamley
Alan Tinker
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9803773A priority Critical patent/SE9803773D0/en
Publication of SE9803773D0 publication Critical patent/SE9803773D0/en
Priority to PCT/SE1999/001988 priority patent/WO2000027842A1/en
Priority to AU14345/00A priority patent/AU1434500A/en
Priority to JP2000581020A priority patent/JP2002529463A/en
Priority to EP99971807A priority patent/EP1124821A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

There are provided novel compounds of formula (I) wherein R<1>, R<2>, R<3>, R<4>, R<5>, A, Q, X, Y, and Z are as defined in the specification, and pharmaceutically acceptable salts thereof, and enantiomers and tautomers thereof; together with processes for their preparation, compositions containing them and their use in therapy. The compounds are inhibitors of the enzyme nitric oxide synthase and are thereby particularly useful in the treatment or prophylaxis of inflammatory disease and pain.
SE9803773A 1998-11-05 1998-11-05 Compounds SE9803773D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE9803773A SE9803773D0 (en) 1998-11-05 1998-11-05 Compounds
PCT/SE1999/001988 WO2000027842A1 (en) 1998-11-05 1999-11-03 Compounds
AU14345/00A AU1434500A (en) 1998-11-05 1999-11-03 Compounds
JP2000581020A JP2002529463A (en) 1998-11-05 1999-11-03 Compound
EP99971807A EP1124821A1 (en) 1998-11-05 1999-11-03 Compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803773A SE9803773D0 (en) 1998-11-05 1998-11-05 Compounds

Publications (1)

Publication Number Publication Date
SE9803773D0 true SE9803773D0 (en) 1998-11-05

Family

ID=20413181

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9803773A SE9803773D0 (en) 1998-11-05 1998-11-05 Compounds

Country Status (5)

Country Link
EP (1) EP1124821A1 (en)
JP (1) JP2002529463A (en)
AU (1) AU1434500A (en)
SE (1) SE9803773D0 (en)
WO (1) WO2000027842A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ142599A0 (en) * 1999-07-05 1999-07-29 Fujisawa Pharmaceutical Co., Ltd. New amide compounds
GB0004153D0 (en) 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
GB0004152D0 (en) 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel compounds
GB0004151D0 (en) 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
AR035700A1 (en) * 2001-05-08 2004-06-23 Astrazeneca Ab DERIVATIVES OF ARILHETEROALQUILAMINA, PHARMACEUTICAL COMPOSITION, USES OF THESE DERIVATIVES FOR THE MANUFACTURE OF MEDICINES, TREATMENT METHODS, AND PROCESS FOR THE PREPARATION OF THESE DERIVATIVES
SE0102640D0 (en) 2001-07-31 2001-07-31 Astrazeneca Ab Novel compounds
JP5279987B2 (en) 2003-05-20 2013-09-04 味の素株式会社 Amide derivatives
DK1867644T3 (en) 2003-07-24 2009-09-21 Euro Celtique Sa Heteroberl-tetrahydropyridyl compounds useful for treating or preventing pain
CA2705411A1 (en) * 2007-12-21 2009-07-02 F. Hoffmann-La Roche Ag Heteroaryl derivatives as orexin receptor antagonists
BRPI0906799A2 (en) 2008-01-11 2015-07-14 Hoffmann La Roche Beta Amyloid Modulators
JP5328816B2 (en) 2008-02-22 2013-10-30 エフ．ホフマン−ラ ロシュ アーゲー Modulator of amyloid β
KR101324414B1 (en) 2008-10-09 2013-11-01 에프. 호프만-라 로슈 아게 Modulators for amyloid beta
AU2009312856A1 (en) 2008-11-10 2010-05-14 F. Hoffmann-La Roche Ag Heterocyclic gamma secretase modulators
US8486967B2 (en) 2010-02-17 2013-07-16 Hoffmann-La Roche Inc. Heteroaryl substituted piperidines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996018617A1 (en) * 1994-12-12 1996-06-20 Merck & Co., Inc. Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
ATE254609T1 (en) * 1995-05-18 2003-12-15 Zeria Pharm Co Ltd AMINOTHIAZOLE DERIVATIVES, MEDICINAL PRODUCTS CONTAINING THEM AND INTERMEDIATE PRODUCTS IN THE PRODUCTION OF THESE COMPOUNDS
JP2000502704A (en) * 1995-12-29 2000-03-07 スミスクライン・ビーチャム・コーポレイション Vitronectin receptor antagonist
CA2251017A1 (en) * 1996-04-10 1997-10-16 Mark E. Duggan .alpha.v.beta.3 antagonists

Also Published As

Publication number Publication date
EP1124821A1 (en) 2001-08-22
AU1434500A (en) 2000-05-29
WO2000027842A1 (en) 2000-05-18
JP2002529463A (en) 2002-09-10

Similar Documents

Publication Publication Date Title
SE9803518D0 (en) Novel compounds
MXPA03010142A (en) Novel arylheteroalkylamine derivatives.
ATE248837T1 (en) QUINUCLIDINE-ACRYLAMIDE
GB0004153D0 (en) Novel use
AU2003278667A1 (en) Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines
SE9701304D0 (en) Compounds
SE9803773D0 (en) Compounds
SE0302756D0 (en) Novel Compounds
SE0203070D0 (en) Novel compounds
SE0102641D0 (en) Novel compounds
AU2001234314A1 (en) Novel phenylheteroalkylamine derivatives
SE0102639D0 (en) Novel compounds
SE0102640D0 (en) Novel compounds
SE0103325D0 (en) Novel compounds
SE9904676D0 (en) Novel compounds
SE9901901D0 (en) Compounds
SE9901530D0 (en) Novel compounds
SE0202280D0 (en) Novel compounds
SE0300907D0 (en) Novel compounds
GB0004151D0 (en) Novel use
SE9802650D0 (en) Compounds
NO20042729L (en) Hexycyclic compounds
SE0000477D0 (en) Novel compounds
SE0202279D0 (en) Novel comppounds
SE0300906D0 (en) Novel compounds